The serum levels of IGF-1, IGFBP-4, and PAPP-A in treated (TP) and untreated patients (UTP) with lung cancer and the control group are shown in Table 2, and the levels in the different histological subgroups are shown in Table 3. This evidence concerns the gene IGF1 and lung carcinoma.